Literature DB >> 6972973

Hapten-specific T cell response to 4-hydroxy-3-nitrophenyl acetyl. X. Characterization of distinct T cell subsets mediating cutaneous sensitivity responses.

M E Sunday, M E Dorf.   

Abstract

NP-O-Succinimide-induced cutaneous sensitivity (CS) responses can be adoptively transferred by NP-primed lymphoid cells into naive K-, I-, or D-compatible recipients. The distinct fine specificities of I- versus D-restricted T cell clones from various strains of mice suggested that presence of different idiotypic receptors on these T cell subsets. We now demonstrate that NP-O-Su immune lymphoid cells are composed of 2 T cell subsets with distinct antigen recognition patterns, as well as different Lyt 2 phenotypes. Thus, I-restricted cells respond to NP-coupled to a protein carrier but not to NP-coupled cells, whereas D-restricted clones react to NP-cells, but not to NP-protein conjugates.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6972973

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  Inhibition of contact sensitivity in human CD4+ transgenic mice by human CD4-specific monoclonal antibodies: CD4+ T-cell depletion is not required.

Authors:  P L Podolin; E F Webb; M Reddy; A Truneh; D E Griswold
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

2.  Mechanism responsible for the induction of I-J restriction on TS3 suppressor cells.

Authors:  M Minami; N Honji; M E Dorf
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307

3.  Haptens can serve as surrogate transplantation antigens in a manner that demonstrates H-2 restriction of graft rejection.

Authors:  J W Streilein; P R Bergstresser
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

4.  Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses.

Authors:  D J Berg; M W Leach; R Kühn; K Rajewsky; W Müller; N J Davidson; D Rennick
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.